ClinVar Miner

Submissions for variant NM_058216.3(RAD51C):c.414G>C (p.Leu138Phe) (rs267606999)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000129800 SCV000184611 likely pathogenic Hereditary cancer-predisposing syndrome 2018-02-02 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Deficient protein function in appropriate functional assay(s),Other data supporting pathogenic classification,Other strong data supporting pathogenic classification,In silico models in agreement (deleterious) and/or completely conserved position in appropriate species
Color RCV000129800 SCV000909442 likely pathogenic Hereditary cancer-predisposing syndrome 2018-06-12 criteria provided, single submitter clinical testing
Counsyl RCV000662981 SCV000785964 likely pathogenic Breast-ovarian cancer, familial 3; Fanconi anemia, complementation group O 2018-01-23 criteria provided, single submitter clinical testing
Invitae RCV000648269 SCV000770083 likely pathogenic Fanconi anemia, complementation group O 2018-11-09 criteria provided, single submitter clinical testing This sequence change replaces leucine with phenylalanine at codon 138 of the RAD51C protein (p.Leu138Phe). The leucine residue is highly conserved and there is a small physicochemical difference between leucine and phenylalanine. This variant is not present in population databases (ExAC no frequency). This variant has been reported in individuals and families with breast cancer and/or ovarian cancer and has been reported to segregate with disease in two of these families (PMID: 20400964, 22451500, 27328445). ClinVar contains an entry for this variant (Variation ID: 6825). Experimental studies have shown that this missense change disrupts protein function, resulting in a defective DNA damage response (PMID: 20400964, 22167183, 24141787, 25292178, 26354865). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
OMIM RCV000007227 SCV000027423 risk factor Breast-ovarian cancer, familial 3 2010-05-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.